ACNATAC gel tb 30 g

7680625130011 CH-62513 D10AF51 10.02.0.
ACNATAC gel tb 30 g
ACNATAC gel tb 30 g
ACNATAC gel tb 30 g
1 / 3
google

Details

Product number
6251301
CPT
-
Packaging group
30
Unit
g
Composition
clindamycini phosphas 12.0 mg corresp. clindamycinum 10.0 mg, tretinoinum 0.25 mg, acidum citricum, dinatrii edetas, polysorbatum 80, trometamolum, carbomerum 981, glycerolum, E 321 0.2 mg, propylis parahydroxybenzoas 0.3 mg, E 218 1.5 mg, aqua purificata q.s. ad gelatum pro 1 g.

Articles (1)

Acnatac, Gel
Gel
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
06/05/2024
Patient information leaflet
Français
06/05/2024
Patient information leaflet
Italien
06/05/2024
Professional SmPC
Allemand
06/05/2024
Professional SmPC
Français
06/05/2024
Professional SmPC
Italien
06/05/2024

Detailed composition

Substance Quantity Type Category
(N/A)
12.0 MG Substance WIZUS
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
0.25 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.2 MG Substance HBESI
(N/A)
0.3 MG Substance HBESI
(N/A)
1.5 MG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 32.85
Specialties list
Yes
Generic
No
SL addition date: 01/12/2016

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
62513
Drug name
Acnatac, Gel
Galenic form
GELK
ATC Code
D10AF51
Authorization status
Z
Dispensation category
A
First authorization
28/03/2014
Authorization expiration date
31/12/9999
IT number
10.02.0.
Domain
Human medicine
Field of application
Topische Behandlung von Akne vulgaris

Packaging details

Description (FR)
ACNATAC gel tb 30 g
Description (DE)
ACNATAC Gel Tb 30 g
Market launch
28/03/2014
Narcotic (BTM)
No